Is Illumina Still the Gamechanger in Genomics Sequencing?

Published on October 4, 2022

Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused